Risk of antibiotics associated with Clostridioides difficile infection: Antibiotic stewardship in action

We examined risk associated with antibiotics used for Clostridioides difficile infection (CDI) at a single site from 2018 through 2020. Overall, 78 patients had nonrecurrent infections. Among inpatient antibiotics, intravenous meropenem had the highest CDI rate (3.56 per 1,000 days of therapy; n = 2...

Descripción completa

Detalles Bibliográficos
Autores principales: Dysangco, Andrew T., Pierce, Tamra M., Bravata, Dawn M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cambridge University Press 2022
Materias:
Concise Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726489/
https://www.ncbi.nlm.nih.gov/pubmed/36483417
http://dx.doi.org/10.1017/ash.2022.286

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9726489/
https://www.ncbi.nlm.nih.gov/pubmed/36483417
http://dx.doi.org/10.1017/ash.2022.286

Ejemplares similares